Mexico’s death toll becomes the world’s third highest, surpassing India’s.

The New York Times | Jan. 29, 2021, 3:38 a.m. | Original

As of Friday, Mexico had recorded 155,145 coronavirus deaths and more than 1.8 million cases. President Andrés Manuel López Obrador has downplayed the threat of the virus.

China Frees Tashi Wangchuk, Tibetan Who Fought for Language Rights

The New York Times | Jan. 29, 2021, 1:46 a.m. | Original

Tashi Wangchuk was sentenced to five years in prison after telling The New York Times that Tibetan language education was being repressed.

My Attempt to Prepare for a Future Without Google

The New York Times | Jan. 28, 2021, 11:03 p.m. | Original

After the tech giant threatened to take its search engine offline in Australia, I’ve been looking into some alternatives.

Your Friday Briefing

The New York Times | Jan. 28, 2021, 10:41 p.m. | Original

Mixed results from Novavax’s vaccine trials.

Protests Continue in Poland After Near-Total Abortion Ban

The New York Times | Jan. 28, 2021, 9:43 p.m. | Original

Demonstrators vowed to keep protesting Poland’s new abortion law, which went into effect Wednesday, tightening the country’s already restrictive laws.

A Washington hospital system apologizes after offering vaccines to wealthy donors.

The New York Times | Jan. 28, 2021, 7:25 p.m. | Original

Pregnant Women Get Conflicting Advice on Covid-19 Vaccines

The New York Times | Jan. 28, 2021, 4:47 p.m. | Original

The W.H.O. and the C.D.C. provide differing views, and experts partly blame a lack of data because expectant mothers have been excluded from clinical trials.

The variant that emerged in South Africa is reported in the U.S. for the first time.

The New York Times | Jan. 28, 2021, 4:08 p.m. | Original

Your Friday Briefing

The New York Times | Jan. 28, 2021, 3:53 p.m. | Original

China cracks down on Lunar New Year travel.

E.U. Pushes for AstraZeneca to Provide More Vaccines

The New York Times | Jan. 28, 2021, 2:54 p.m. | Original

The European Union is pushing for AstraZeneca to supply more doses of its Covid-19 vaccine after announcing on Wednesday that it would cut deliveries by 60 percent due to manufacturing issues.